[{"Assets_0_Q3_USD":212704000.0,"CommonStockSharesOutstanding_0_Q3_shares":39389515.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":2060000.0,"NetIncomeLoss_1_Q3_USD":-19400000.0,"NetIncomeLoss_3_Q3_USD":-53361000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":38034216.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":34696835.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":38034216.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":34696835.0,"StockholdersEquity_0_Q3_USD":149530000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":5062000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":7936000.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]